Cognex Corporation (NASDAQ:CGNX) Receives $44.93 Consensus Price Target from Brokerages

Shares of Cognex Corporation (NASDAQ:CGNX) have been given an average rating of “Moderate Buy” by the eighteen ratings firms that are currently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, eight have issued a hold rating, seven have assigned a buy rating and two have given a strong buy rating to the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $44.9333.

Several research analysts recently commented on the stock. JPMorgan Chase & Co. started coverage on shares of Cognex in a report on Monday, September 15th. They issued a “neutral” rating and a $45.00 target price on the stock. Barclays set a $55.00 price objective on Cognex and gave the stock an “overweight” rating in a research note on Tuesday, October 7th. Truist Financial set a $45.00 target price on Cognex and gave the company a “hold” rating in a research note on Wednesday, October 8th. Melius raised Cognex from a “hold” rating to a “buy” rating and set a $60.00 target price on the stock in a report on Thursday, July 10th. Finally, Citigroup reiterated a “neutral” rating and set a $37.00 price target (up from $30.00) on shares of Cognex in a report on Monday, July 14th.

Cognex Stock Performance

CGNX opened at $46.04 on Friday. The firm has a market cap of $7.73 billion, a P/E ratio of 64.85 and a beta of 1.50. The business has a 50 day moving average price of $44.62 and a 200 day moving average price of $35.42. Cognex has a twelve month low of $22.67 and a twelve month high of $47.52.

Cognex (NASDAQ:CGNX) last released its quarterly earnings results on Wednesday, July 30th. The scientific and technical instruments company reported $0.25 EPS for the quarter, beating analysts’ consensus estimates of $0.23 by $0.02. Cognex had a net margin of 13.13% and a return on equity of 6.65%. The company had revenue of $249.09 million for the quarter, compared to analyst estimates of $246.70 million. During the same quarter last year, the firm posted $0.23 earnings per share. The company’s quarterly revenue was up 4.2% compared to the same quarter last year. Cognex has set its Q3 2025 guidance at 0.240-0.290 EPS. As a group, analysts anticipate that Cognex will post 0.61 earnings per share for the current fiscal year.

Cognex Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, August 28th. Shareholders of record on Thursday, August 14th were issued a $0.08 dividend. The ex-dividend date of this dividend was Thursday, August 14th. This represents a $0.32 dividend on an annualized basis and a yield of 0.7%. Cognex’s dividend payout ratio is 45.07%.

Insider Buying and Selling at Cognex

In other news, EVP Sheila Marie Dipalma sold 2,000 shares of the business’s stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $45.03, for a total transaction of $90,060.00. Following the sale, the executive vice president directly owned 6,582 shares in the company, valued at approximately $296,387.46. The trade was a 23.30% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 1.60% of the company’s stock.

Institutional Trading of Cognex

Large investors have recently added to or reduced their stakes in the company. TD Waterhouse Canada Inc. acquired a new stake in shares of Cognex in the second quarter valued at $29,000. Penserra Capital Management LLC acquired a new position in Cognex in the second quarter valued at approximately $29,000. Geneos Wealth Management Inc. boosted its stake in Cognex by 402.2% in the first quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock valued at $27,000 after acquiring an additional 736 shares during the last quarter. Farther Finance Advisors LLC grew its holdings in Cognex by 439.4% during the 1st quarter. Farther Finance Advisors LLC now owns 971 shares of the scientific and technical instruments company’s stock worth $29,000 after acquiring an additional 791 shares during the period. Finally, GAMMA Investing LLC grew its stake in shares of Cognex by 155.3% during the first quarter. GAMMA Investing LLC now owns 1,062 shares of the scientific and technical instruments company’s stock worth $32,000 after purchasing an additional 646 shares during the period. 88.12% of the stock is owned by institutional investors.

Cognex Company Profile

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.